Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefazolin prophylaxis in clean non-prosthetic surgery
NCT03595852Completed
- Sponsor
- University of Rwanda
- Start
- Mar 2018
- Primary completion
- Sep 2018
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Randomised, triple-blind trial of cefazolin in surgical site infection (SSI) (2 arms), sponsored by University of Rwanda. Primary endpoint: Surgical site infection at 30 days. Started Mar 2018; status: completed.
02
Drugs
cefazolin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT03595852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03595852.